SOLAR- Frailty Screening and Multidisciplinary Assessment of Older Adults in the Emergency Department
SOLAR
The Impact of Frailty Screening of Older Adults With muLtidisciplinary Assessment of Those At Risk During Emergency Hospital Attendance on the Quality, Safety and Cost-effectiveness of Care (SOLAR): a Randomised Controlled Trial
1 other identifier
interventional
229
1 country
1
Brief Summary
SOLAR is a randomised control trial exploring the role of Comprehensive Geriatric Assessment (CGA) in older adults who screen positive for frailty based on the Identification of Seniors at Risk (ISAR) tool the the Emergency Department and Acute Medical Assessment Unit of a University Teaching Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2020
CompletedStudy Start
First participant enrolled
November 9, 2020
CompletedFirst Posted
Study publicly available on registry
November 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2023
CompletedJune 13, 2023
June 1, 2023
6 months
November 2, 2020
June 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Experience Times (PET)
PET time recorded as time of arrival at the ED to discharge or admission
Exact time of admission or discharge from ED will be collected at 30 days from index visit
Time to admission or discharge and if for admission, time that the bed is booked to go to medical wards.
This is the time that the patient is either discharged or identified for admission and bed booked to go to the medical wards
Exact time of admission or discharge from ED will be collected at 30 days from index visit
Secondary Outcomes (7)
Rate of ED Representation
30 days and 6 months
Mortality
30 days and 6 months
Rate of Hospital Readmission
30 days and 6 months
Functional Decline
30 days and 6 months
Patient Satisfaction-
30 days
- +2 more secondary outcomes
Study Arms (2)
Control Arm
NO INTERVENTIONThe control group will obtain usual medical care in the Emergency Department and Acute Medical Assessment Unit
SOLAR arm
EXPERIMENTALThe SOLAR arm will obtain a comprehensive geriatric assessment which will be provided by a geriatric doctor, physiotherapist, occupational therapist, social worker, pharmacist and specialist nurse.
Interventions
The participants will obtain a multidisciplinary assessment regarding their medical conditions, medication review, cognitive assessment, functional assessment, gait and balance assessment by senior clinicians and a management plan will be implemented.
Eligibility Criteria
You may qualify if:
- Older adults aged 75 years or over
- Medically stable as deemed by the treating physician
- A score of 2 or above on the ISAR
- Present with a medical complaint
You may not qualify if:
- Those under the age of 75 years
- A score of less than 2 on the ISAR
- Acute myocardial infarction, stroke or non-medical problems e.g. surgical or psychiatric issues
- Patients who are medically unstable
- If neither the patient nor carer can communicate in English sufficiently to complete consent or baseline assessment
- Confirmed or highly suspicious of symptoms for COVID 19.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Limericklead
- University Hospital of Limerickcollaborator
Study Sites (1)
University Hospital Limerick
Limerick, v, Ireland
Related Publications (3)
McCusker J, Bellavance F, Cardin S, Trepanier S, Verdon J, Ardman O. Detection of older people at increased risk of adverse health outcomes after an emergency visit: the ISAR screening tool. J Am Geriatr Soc. 1999 Oct;47(10):1229-37. doi: 10.1111/j.1532-5415.1999.tb05204.x.
PMID: 10522957BACKGROUNDLeahy A, Barry L, Corey G, Whiston A, Purtill H; SOLAR team; Shanahan E, Shchetkovsky D, Ryan D, O'Loughlin M, O'Connor M, Galvin R. Frailty screening with comprehensive geriatrician-led multidisciplinary assessment for older adults during emergency hospital attendance in Ireland (SOLAR): a randomised controlled trial. Lancet Healthy Longev. 2024 Nov;5(11):100642. doi: 10.1016/j.lanhl.2024.100642. Epub 2024 Nov 11.
PMID: 39541993DERIVEDLeahy A, McNamara R, Reddin C, Corey G, Carroll I; SOLAR team; O'Neill A, Flannery D, Devlin C, Barry L, MacCarthy B, Cummins N, Shanahan E, Shchetkovsky D, Ryan D, O'Connor M, Galvin R. The impact of frailty Screening of Older adults with muLtidisciplinary assessment of those At Risk during emergency hospital attendance on the quality, safety and cost-effectiveness of care (SOLAR): a randomised controlled trial. Trials. 2021 Aug 31;22(1):581. doi: 10.1186/s13063-021-05525-w.
PMID: 34465368DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rose Galvin, phD
University of Limerick
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be unaware if the participant was in control or intervention arm
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2020
First Posted
November 16, 2020
Study Start
November 9, 2020
Primary Completion
May 13, 2021
Study Completion
January 15, 2023
Last Updated
June 13, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- The study protocol will be prepared for publication in an open access journal. the study protocol will include the Statistical Analysis Plan and Informed Consent Form. It is likely to be published in Quarter 2 of 2021. The Clinical Study Report will be made publicly available in the form of a peer reviewed publication in late 2021.
- Access Criteria
- Supporting information will be available on peer reviewed publications.
Individual data will be stored on a data repository after the study analysis.